Parallax Volatility Advisers
CORV

Parallax Volatility Advisers’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Parallax Volatility Advisers’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,226
Closed -$4K – 4147
2019
Q1 		$4K Sell
1,226
-36,670
-97% -$119K ﹤0.01% 2596
2018
Q4 		$94K Buy
37,896
+4,459
+13% +$14.8K ﹤0.01% 1954
2018
Q3 		$134K Buy
+33,437
New +$147K ﹤0.01% 1688

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $161M AUM 27.24% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $763M AUM 108.51% 1-Year Est. Return
AIP
ARS Investment Partners New York $2.29B AUM 113.95% 1-Year Est. Return

Parallax Volatility Advisers's CORV Position: Q2 2019 in Review

Parallax Volatility Advisers sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q2 2019, closing a stake of 1,226 shares — an estimated $4K sold.

Parallax Volatility Advisers first reported a position in CORV in Q3 2018 and held it in 3 quarters. The position peaked at $134K in Q3 2018. 36 funds tracked by Wall St. Rank hold CORV as of Q2 2019.

  • Parallax Volatility Advisers reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q2 2019 after selling out during the quarter.
  • Parallax Volatility Advisers sold 1,226 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q2 2019, an estimated $4K.
  • Parallax Volatility Advisers first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2018 and held it in 3 quarters.
  • Parallax Volatility Advisers's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $134K in Q3 2018.
  • 36 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q2 2019.

Based on Parallax Volatility Advisers's 13F filing for Q2 2019, filed 14 Aug 2019.